Purchase of this book includes free trial access to www.million-books.com where you can read more than a million books for free. This is an OCR edition with typos. Excerpt from book: Pharmaceutical Considerations DIFFICULTIES here begin with the crude drug. C. J. Zufall in a paper1 asserts that the pharmacopeial descriptions of aconite, apocynum, belladonna leaves, berberis, buchu, capsicum, cardamon, coca, colchicum seed, cubeb, ergot, grindelia, lupulin, savin, scoparius, viburnum opulus and viburnum prunifolium are more or less defective. This paper is one of many bearing upon the same problem, a matter of very considerable importance and one that merits the most careful investigation. The integrity of our botanic crudes is the foundation of the success or failure of botanic remedies. Theoretically considered, the United States Pharmacopeia products should be those of highest development from the scientific and the clinical standpoints, yet "New and NonofBcial Remedies," 1916 edition, lists and describes proprietary products of the following botanic drugs: Various agar preparations, certain vegetable tar products, a few atropine derivatives, chinosol, eucodin, stypticin, styptol, several digitalis products, cymarin, ouabain, various products of ergot, filmaron, aristol, several ipecac products, B. bulgaricus and Kefir fungi specialties, several carbohydrate medicinal foods, coryfin, several opium principles and derivatives, phloridzin, various pollen extracts, numerous quinine derivatives, sandalwood oil derivatives, euscopol,tannic acid derivatives, apinol, urease, valeric esters, validol camphoratum, several caffeine-like bodies, cerolin, and numerous others. lJour. Amer. Pharmaceutical Ass'n, April, 1915. Among non-proprietary and also non-official products made by designated manufacturers are named these: Agaric acid, homatropine hydrochloride, ber- berine hydrochloride, cantharidin, cypress oil, digi- toxin, special ergot products, emetine...